P Squared Asset Management Ag Horizon Therapeutics Public LTD CO Transaction History

P Squared Asset Management Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $1.23 Million - $1.43 Million	12,391 Added 0.62%	2,001,749 $232 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $19.4 Million - $22.6 Million	-201,487 Reduced 9.2%	1,989,358 $205 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $63 Million - $66.6 Million	587,145 Added 36.61%	2,190,845 $239 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $100 Million - $183 Million	1,603,700 New	1,603,700 $183 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of P Squared Asset Management Ag, based on Form 13F filings with the SEC.

Stay updated on P Squared Asset Management Ag with notifications on news.